ARTICLE | Company News
Cellectis, National Institutes of Health gene/cell therapy news
October 29, 2012 7:00 AM UTC
NIH awarded Cellectis' commercial subsidiary, Cellectis bioresearch Inc., a contract worth up to $6.9 million over three years. Cellectis will generate induced pluripotent stem (iPS) cell lines of res...